The U.S. is experiencing events that are either the first stages of a widespread avian influenza outbreak or a fire drill that will show how well the nation is prepared for an outbreak. The U.S. has not stepped up to meet the challenge, Rick Br

Ep. 61 - Vas Narasimhan: How New Data Fit Novartis’ Growth Plan

17 days ago 32m 11s

Differentiating on tolerability, raising the bar for efficacy and concentrating small molecule development on indications with minimal IRA exposure are all pieces of Novartis CEO Vasant Narasimhan’s strategy to break into the top pharmas by U.S

Ep. 60 - JMM John Maraganore: A higher bar for investment is a credit to biotech

18 days ago 36m

“The bar has gotten higher because science has gotten so much better,” John Maraganore says on the latest BioCentury Show. Reflecting on the capital markets and the state of innovation, the founder and former CEO of Alnylam painted a picture of

Ep. 59 - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more

May 16th, 2024 32m 9s

“I’m a short-term pessimist and a long-term optimist” about the potential for AI to transform drug development, Derek Lowe, author of the In the Pipeline blog, told BioCentury Washington Editor Steve Usdin on the latest BioCentury Show. Lowe's

Ep. 58 - Ysios' Karen Wagner: How Europe's Biotechs Can Rise Above the Noise

May 2nd, 2024 30m 54s

It sounds obvious, but still needs saying, says Ysios Capital's Karen Wagner. “How do you rise above the noise? By having the most spectacular data.” In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Wagner discussed

Ep. 57 - BMS's Robert Plenge: Causal biology is the North Star of R&D

May 2nd, 2024 31m 17s

This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.Within the framework of target, modality and path to cl

Ep. 54 - Arthur Caplan: Lessons From a Compassionate Use Firestorm

Apr 17th, 2024 30m 52s

This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.On the tenth anniversary of a viral media campaign for

Ep. 55 - Bruce Booth: Biotech Benefiting from Belt-Tightening

Apr 17th, 2024 32m 10s

This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.Atlas Venture’s Bruce Booth believes the belt-tightenin

Ep. 56 - BIO’s John Crowley on the Biosecure Act

Apr 17th, 2024 36m 55s

This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.BIO CEO John Crowley believes that biotech is part of a

Ep. 52 - Khoo Shih on Scaling Singapore Biotech

Apr 17th, 2024 31m 27s

This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.Success for the Singapore biotech project will take a g

Ep. 53 - Bob Nelsen on AI, China and the IRA

Apr 17th, 2024 35m 26s

This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.In a wide-ranging conversation with BioCentury, Bob Nel

Rate